logo
episode-header-image
May 15
13m 15s

Breaking the Code: Mechanisms and Future...

ReachMD
About this episode
Host: Eric Merrell, MD
Guest: Syed Shahzad Mustafa, MD
Guest: Glenn Schneider, MD

Part of the educational program Bridging Specialties®: Timely Diagnosis and Treatment for Refractory Chronic Cough, this activity explores emerging scientific insights and therapeutic advances shaping the management of refractory chronic cough (RCC). Despite appropriate evaluation and treatment of common etiologies, many patients continue to experience persistent cough consistent with cough hypersensitivity syndrome. Advances in understanding ATP–P2X3 signaling and neural mechanisms have reshaped the conceptual framework for RCC and informed the development of emerging therapies. This activity reviews the neurobiology of cough hypersensitivity, current management gaps, and the evolving therapeutic landscape. Clinicians will gain insight into mechanism-based care strategies and patient-centered counseling considerations in RCC management.

Up next
May 7
Diagnostic Challenges in Refractory Chronic Cough: From Burden to Solutions
Host: Sandhya Khurana, MD, FCCP Guest: Syed Shahzad Mustafa, MD Guest: Ashley Wilk, DO, DipABLM Part of the educational program Bridging Specialties®: Timely Diagnosis and Treatment for Refractory Chronic Cough, this activity examines the diagnostic challenges associated with ref ... Show More
16m 15s
Mar 2026
What Type 2 Inflammation in COPD Means for Treatment Decision Making
Host: Stephanie Christenson, MD Guest: Diego Maselli, MD, FCCP COPD is increasingly recognized as a heterogeneous disease, and for a subset of patients, type 2 inflammation plays a meaningful role in exacerbation risk and treatment response. Given that, Drs. Stephanie Christenson ... Show More
15 m
Jan 2025
Optimizing NTM Care: Expert Insights on Diagnosis and Treatment
Guest: Ashwin Basavaraj, MD Guest: Keren Bakal, MD Guest: Nathan Falk, MD, MBA, FAAFP Guest: Amy Springer, NP Often mistaken for COPD or asthma, bronchiectasis and nontuberculous mycobacteria (NTM) can be difficult to recognize and test for, often delaying diagnosis and effective ... Show More
1s
Recommended Episodes
Nov 2021
#306 Bronchiectasis and NTM: You can’t get enough sputum!
Take a deep breath and inhale high-yield knowledge molecules about the perplexing conditions known as bronchiectasis and NTM (nontuberculous mycobacteria)! Learn the pitfalls and pearls of diagnosis and management from one of the world’s experts, the great Dr. PJ McShane from UT ... Show More
1h 19m
Dec 2021
Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced NSCLC
CHEST December 2021, Volume 160, Issue 6 Gerard A. Silvestri, MD, FCCP, and Adam H. Fox, MD, join CHEST Podcast Moderator Dominique Pepper, MD, to discuss the current knowledge and practice of pulmonologists regarding biomarker testing and targeted therapies in advanced non-small ... Show More
32m 8s
Mar 2020
Bronchiectasis (Wigan based)
<p>Bronchiectasis can sometimes be overlooked amongst the other, more common lung conditions such as COPD. Because of this, it can be difficult for primary care clinicians to be fully aware of how to comprehensively diagnose and manage patients who have this condition. </p> <p>Li ... Show More
33m 23s
Jun 2024
ASCO24: Transforming the Lung Cancer Treatment Landscape
<p class="paragraph" style= "margin: 0in; vertical-align: baseline;"><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Drs. Vamsi Velcheti and Nathan Pennell discuss novel approaches and key studies in lung cancer that were showcased at the 2024 ASCO Annu ... Show More
33m 17s
Dec 2024
Connecting Radiology & Surgery in ILC Care - Sponsored by GE HealthCare
Dr. Linda Chu is joined by Dr. Matthew Covington and Dr. Regina Rosenthal to discuss the challenges in diagnosing and treating invasive lobular carcinoma (ILC) of the breast. They explore imaging difficulties, unique metastatic patterns, and strategies for improving detection and ... Show More
25m 36s
Apr 2024
Optimizing Novel Therapies and Surgery in Early-Stage NSCLC
<p>Doctors Vamsi Velcheti, Sandip Patel, and Michael Zervos discuss recent updates on the management of early-stage non-small cell lung cancer (NSCLC), including the optimization of neoadjuvant and adjuvant treatment options for patients and the role of surgery in the era of targ ... Show More
31m 31s
May 2024
2024 ATS Highlights
Dr. Kristen Highland speaks with Drs. Peter Mazzone and Vickram Tejwani about the recent 2024 American Thoracic Society Conference. Topics discussed include exposure-related mutations in non-smokers' lungs, doing better at getting the right people to be screened and new tools in ... Show More
25m 54s
Dec 2022
Ep 177 Bronchiolitis – Diagnostic Challenges and Management Pitfalls
In this main episode podcast Anton discusses with world expert and bronchiolitis researcher Dr. Suzanne Schuh, the challenges of the diagnosis and management of bronchiolitis during a time of crisis in pediatric emergency medicine and offers some evidence-based solutions to impro ... Show More
59m 56s
Oct 2025
Ep. 267 Sequencing Therapies in NMIBC Management with Dr. Mark Tyson and Dr. Suzanne Merrill
New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor ... Show More
1 h